Capricor Stock Jumps 14% as WMS Opens HOPE-3 Poster Featuring FDA-Filed Data
5 Articles
5 Articles
Capricor Stock Jumps 14% as WMS Opens HOPE-3 Poster Featuring FDA-Filed Data
Capricor Therapeutics Inc. (NASDAQ: CAPR) shares jumped 13.54% to $9.73 in Wednesday pre-market trading amid the opening of the World Muscle Society’s 2026 congress, where Capricor’s late-breaking HOPE-3 open-label-extension poster on Deramiocel was available to registered delegates on the virtual platform.Visit Website
The Capricor Therapeutics shares closed on Tuesday, September 29 at $8.57, down by +1,61%. The session recorded a maximum of 8,97 and a minimum of 8,50, with over 2,2 million shares exchanged. The technical picture daily remains dominated by the decrease, but news arrived after the closure could change the short narrative [...]
Capricor Therapeutics, Inc. stock falls to $8.57 as bearish trend holds
Capricor Therapeutics, Inc. stock closed Tuesday at $8.57 , down 1.61%, with the daily trend firmly bearish. Intraday charts, however, signal consolidation rather than continuation. After-hours deramiocel HOPE-3 data and macro yield pressure add tension to an already complex technical picture. CAPR...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
